Highlights
- 1
- 2Nature structural & molecular biology · 2024
- 3
Publications
104 publications
Funding
13 grantsView NIH portfolio on RePORTER ↗
Active
2 grants- PIR01HL177433-02Structural Dynamics and Regulatory Mechanisms of Atrial Natriuretic Peptide ReceptorNational Heart, Lung, and Blood Institute · 2024–2028
- PISRA 227819-01Identification of Fascin InhibitorsNovita Pharmaceuticals, Inc. · 2024–2026Contract
Completed grants (11)
- PIR01GM138676-04Molecular Basis of B1-Adrenergic Receptor FunctionNational Institute of General Medical Sciences · 2020–2025
- PIR01HL130478-04Functions of G-proteins in Endothelial CellsNational Heart, Lung, and Blood Institute · 2016–2020
- Sub-PINPRP 7-709-3-195 / QNRFG Protein-Coupled Receptors in the Regulation of Oocyte Meiotic ArrestQatar National Research Fund · 2015–2018 · via Weill Cornell Medical College/Qatar
- PIR01HL091525-05EWOSignaling Mechanisms of Heterotrimeric G ProteinsNational Heart, Lung, and Blood Institute · 2008–2014
- PIR01CA136837-03Migrastatin Analogues and Inhibition of Tumor MetastasisNCI · 2009–2013 · via NIH RePORTER
- PIR01GM084191-04EWOThe Rac-cGMP Signaling PathwayNational Institute of General Medical Sciences · 2009–2012
- PIR01GM056904-08Signaling Mechanisms of G Protein-coupled ReceptorsNIGMS · 1998–2007 · via NIH RePORTER
- PIR01DK043036-13THYROTROPIN RELEASING HORMONE RECEPTOR MOLECULAR BIOLOGYNIDDK · 1990–2005 · via NIH RePORTER
Honors & distinctions
1 honor
- Fellow · American Association for the Advancement of Science · 2012
Available technologies
1 technologyView full WCM portfolio ↗
News mentions
2 mentionsView all WCM news ↗
- Receptor's Structure Reveals How It Functions in Heart DiseaseNovember 14, 2024
Weill Cornell Medicine researchers have determined the full-length structure of a blood pressure-regulating hormone receptor for the first time, uncovering how it functions, which may enable better drug targeting of the receptor for diseases like hypertension and heart failure.
- New Discovery May Help Reduce Side Effects of Multiple Sclerosis DrugsMarch 4, 2022
Investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have discovered how a drug for multiple sclerosis interacts with its targets, a finding that may pave the way for better treatments.
Mentoring
3 menteesAll publications with mentees →
External relationships
Leadership Roles
Novita Pharmaceuticals, Inc.
Ownership
Novita Pharmaceuticals, Inc.
Advisory/Scientific Board Member
Novita Pharmaceuticals, Inc.
Proprietary Interest
Novita Pharmaceuticals, Inc.